TTYP01 not checked
Shanghai Auzone Biological Technology Co., Ltd.
FollowEvery change as it happens, and a Monday email
Trials
2 active
5 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Taken with a moderate amount of warm water or after disperse in a moderate amount of warm water, at least 60 minutes before breakfast and dinner.”In the company’s words, NCT06757504 on ClinicalTrials.gov
- Main trialPhase 2
- “This is a multi-center, randomized, double-blind, multiple dose levels, parallal group, placebo-controlled study, to evaluate the safety, PK profiles and preliminary efficacy of TTYP01 tablets in adolescents and children with ASD.”In the company’s words, NCT06757504 on ClinicalTrials.gov
- Other names
- Edaravone tablet · Edaravone tablets
- Copy of
- Radicava (Shionogi), Radicava ORS (Shionogi)Tested side by side with the original in NCT06107205, NCT06107205
Other drugs for Autism Spectrum Disorder (ASD)
- CM-ATCuremark · Phase 3
- NTI164Fenix Innovation Group · Phase 3
- Xanomeline/Trospium ChlorideBristol Myers Squibb · Phase 3
- CodabakalnerSpinogenix · Phase 2/3
- LumateperoneIntra-Cellular Therapies, Inc. · Phase 3
- ML-004MapLight Therapeutics · Phase 2
Coming up2
- 30 Jun 2027Phase 2 trial completes · ClinicalTrials.gov
- 23 Oct 2028Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 20 NovCompletion date moved: 2026-02-06 to 2027-06-30 · ClinicalTrials.gov NCT06757504
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 30 Jun 2027 | Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD | |
| Phase 2Recruiting | 23 Oct 2028 | A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease | |
| Phase 3Completed | 17 Jun 2024 | Evaluate the Efficacy and Safety of TTYP01 Tablets in the Treatment of Acute Ischemic Stroke | |
| Phase 1Completed | 17 Dec 2020 | A Study of TTYP01 in Healthy Adult Subjects | |
| Phase 1Completed | 14 Dec 2023 | Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026